Author Question: Which of the following would be a reason for a drug company NOT to pursue expensive clinical trails ... (Read 180 times)

future617RT

  • Hero Member
  • *****
  • Posts: 543
Which of the following would be a reason for a drug company NOT to pursue expensive clinical trails with a new drug?
 
  A. The drug produces no side effects.
  B. The drug produces side effects.
  C. The therapeutic index is greater than 1.
  D. The therapeutic index is less than 1

Question 2

What kind of name is Provigil (an alerting drug)?
 
  A. chemical name
  B. generic name
  C. brand name
  D. none of the above



poopface

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

D

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library